Accounting for Cured Patients in Cost-Effectiveness Analysis. [electronic resource]
Producer: 20170424Description: 705-709 p. digitalISSN:- 1524-4733
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- adverse effects
- Antineoplastic Agents -- adverse effects
- Bias
- Cost-Benefit Analysis
- Drug Costs
- Female
- Glycoproteins -- adverse effects
- Humans
- Ipilimumab
- Kaplan-Meier Estimate
- Male
- Melanoma -- drug therapy
- Middle Aged
- Models, Economic
- Quality-Adjusted Life Years
- Randomized Controlled Trials as Topic
- Remission Induction
- Skin Neoplasms -- drug therapy
- Survivors
- Time Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.